$CCXI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ChemoCentryx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ChemoCentryx, Inc.. Get notifications about new insider transactions in ChemoCentryx, Inc. for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 01 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.92 | 25,154 | 123,775 | 1,105,733 | 1.1 M to 1.1 M (+2.33 %) |
Nov 01 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.92 | 45,406 | 223,429 | 1,982,696 | 1.9 M to 2 M (+2.34 %) |
Nov 01 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.97 | 44,584 | 221,373 | 1,080,579 | 1 M to 1.1 M (+4.30 %) |
Nov 01 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.97 | 79,998 | 397,214 | 1,937,290 | 1.9 M to 1.9 M (+4.31 %) |
Nov 01 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.04 | 50,339 | 253,693 | 1,035,995 | 985.7 K to 1 M (+5.11 %) |
Nov 01 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.04 | 90,744 | 457,323 | 1,857,292 | 1.8 M to 1.9 M (+5.14 %) |
Oct 10 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.26 | 29,564 | 155,445 | 985,656 | 956.1 K to 985.7 K (+3.09 %) |
Oct 10 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.26 | 53,271 | 280,094 | 1,766,548 | 1.7 M to 1.8 M (+3.11 %) |
Oct 10 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.35 | 401,675 | 2,148,961 | 956,092 | 554.4 K to 956.1 K (+72.45 %) |
Oct 10 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.31 | 30,406 | 161,310 | 554,417 | 524 K to 554.4 K (+5.80 %) |
Oct 10 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.35 | 726,626 | 3,887,449 | 1,713,277 | 986.7 K to 1.7 M (+73.65 %) |
Oct 10 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.31 | 47,812 | 253,652 | 986,651 | 938.8 K to 986.7 K (+5.09 %) |
Oct 07 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.49 | 38,599 | 212,071 | 524,011 | 485.4 K to 524 K (+7.95 %) |
Oct 07 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.49 | 70,826 | 389,132 | 938,839 | 868 K to 938.8 K (+8.16 %) |
Sep 16 2013 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Buy | P | 6.03 | 10,000 | 60,257 | 10,000 | 0 to 10 K |
Sep 13 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 6.09 | 3,370 | 20,520 | 485,412 | 482 K to 485.4 K (+0.70 %) |
Sep 13 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 6.09 | 6,307 | 38,404 | 868,013 | 861.7 K to 868 K (+0.73 %) |
Sep 13 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.94 | 105,892 | 629,136 | 482,042 | 376.2 K to 482 K (+28.15 %) |
Sep 13 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.94 | 210,066 | 1,248,065 | 861,706 | 651.6 K to 861.7 K (+32.24 %) |
Aug 14 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 3,676 | 2,206 | 11,677 | |
Aug 14 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 1,783 | 7,667 | 26,821 | |
Aug 14 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 12.90 | 3,676 | 47,435 | 18,750 | 22.4 K to 18.8 K (-16.39 %) |
Aug 14 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 3,676 | 2,206 | 22,426 | 18.8 K to 22.4 K (+19.61 %) |
Aug 14 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 12.89 | 1,783 | 22,991 | 18,750 | 20.5 K to 18.8 K (-8.68 %) |
Aug 14 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 1,783 | 7,667 | 20,533 | 18.8 K to 20.5 K (+9.51 %) |
Aug 05 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 13.42 | 5,000 | 67,083 | 40,000 | 45 K to 40 K (-11.11 %) |
Aug 09 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 5,000 | 30,000 | 55,966 | |
Aug 09 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 13.26 | 5,000 | 66,283 | 53,594 | 58.6 K to 53.6 K (-8.53 %) |
Aug 09 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 5,000 | 30,000 | 58,594 | 53.6 K to 58.6 K (+9.33 %) |
Aug 05 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 13.82 | 6,250 | 86,378 | 18,750 | 25 K to 18.8 K (-25.00 %) |
Jul 26 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 14.28 | 165,000 | 2,356,200 | 165,000 | |
Jul 26 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | A | 14.28 | 70,000 | 999,600 | 70,000 | |
Jul 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | A | 14.28 | 70,000 | 999,600 | 70,000 | |
Jul 26 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | A | 14.28 | 70,000 | 999,600 | 70,000 | |
Jul 26 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | A | 14.28 | 70,000 | 999,600 | 70,000 | |
Jul 19 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 3,676 | 2,206 | 15,353 | |
Jul 19 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 1,783 | 7,667 | 28,604 | |
Jul 19 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 14.52 | 3,676 | 53,369 | 25,000 | 28.7 K to 25 K (-12.82 %) |
Jul 19 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 3,676 | 2,206 | 28,676 | 25 K to 28.7 K (+14.70 %) |
Jul 19 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 14.51 | 1,783 | 25,869 | 25,000 | 26.8 K to 25 K (-6.66 %) |
Jul 19 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 1,783 | 7,667 | 26,783 | 25 K to 26.8 K (+7.13 %) |
Jul 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 1,666 | 9,996 | 60,966 | |
Jul 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 3,334 | 20,004 | 24,761 | |
Jul 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 5,000 | 30,000 | 28,095 | |
Jul 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.56 | 5,000 | 72,790 | 53,594 | 58.6 K to 53.6 K (-8.53 %) |
Jul 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 1,666 | 9,996 | 58,594 | 56.9 K to 58.6 K (+2.93 %) |
Jul 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 3,334 | 20,004 | 56,928 | 53.6 K to 56.9 K (+6.22 %) |
Jul 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.52 | 5,000 | 72,604 | 53,594 | 58.6 K to 53.6 K (-8.53 %) |
Jul 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 5,000 | 30,000 | 58,594 | 53.6 K to 58.6 K (+9.33 %) |
Jul 17 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.54 | 2,585 | 37,595 | 2,148,687 | 2.2 M to 2.1 M (-0.12 %) |
Jul 17 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.37 | 19,504 | 280,360 | 2,151,272 | 2.2 M to 2.2 M (-0.90 %) |
Jul 03 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 13.88 | 6,250 | 86,758 | 25,000 | 31.3 K to 25 K (-20.00 %) |
Jul 03 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.50 | 311 | 4,510 | 2,170,776 | 2.2 M to 2.2 M (-0.01 %) |
Jul 03 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 13.43 | 5,000 | 67,157 | 45,000 | 50 K to 45 K (-10.00 %) |
Jul 02 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 36,942 | 73,884 | 105,000 | |
Jul 02 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 14.31 | 36,942 | 528,658 | 0 | 36.9 K to 0 (-100.00 %) |
Jul 02 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 36,942 | 73,884 | 36,942 | 0 to 36.9 K |
Jun 27 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 3,016 | 18,096 | 2,500 | |
Jun 27 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 117 | 702 | 5,516 | |
Jun 27 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 1,867 | 11,202 | 5,633 | |
Jun 27 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 3,016 | 42,224 | 53,594 | 56.6 K to 53.6 K (-5.33 %) |
Jun 27 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 3,016 | 18,096 | 56,610 | 53.6 K to 56.6 K (+5.63 %) |
Jun 27 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 117 | 1,638 | 53,594 | 53.7 K to 53.6 K (-0.22 %) |
Jun 27 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 117 | 702 | 53,711 | 53.6 K to 53.7 K (+0.22 %) |
Jun 27 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 1,867 | 26,138 | 53,594 | 55.5 K to 53.6 K (-3.37 %) |
Jun 27 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 1,867 | 11,202 | 55,461 | 53.6 K to 55.5 K (+3.48 %) |
Jun 25 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 13.00 | 6,250 | 81,250 | 31,250 | 37.5 K to 31.3 K (-16.67 %) |
Jun 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 5,000 | 30,000 | 7,500 | |
Jun 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 12.00 | 5,000 | 60,001 | 53,594 | 58.6 K to 53.6 K (-8.53 %) |
Jun 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 5,000 | 30,000 | 58,594 | 53.6 K to 58.6 K (+9.33 %) |
Jun 20 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 1,783 | 7,667 | 30,387 | |
Jun 20 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 12.47 | 1,783 | 22,228 | 37,500 | 39.3 K to 37.5 K (-4.54 %) |
Jun 20 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 1,783 | 7,667 | 39,283 | 37.5 K to 39.3 K (+4.75 %) |
Jun 05 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 13.86 | 1,502 | 20,822 | 50,000 | 51.5 K to 50 K (-2.92 %) |
Jun 05 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 13.09 | 3,498 | 45,772 | 51,502 | 55 K to 51.5 K (-6.36 %) |
May 31 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 10,653 | 21,306 | 141,942 | |
May 31 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 2,117 | 4,234 | 152,595 | |
May 31 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 14.28 | 10,653 | 152,140 | 0 | 10.7 K to 0 (-100.00 %) |
May 31 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 10,653 | 21,306 | 10,653 | 0 to 10.7 K |
May 31 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 14.27 | 2,117 | 30,211 | 0 | 2.1 K to 0 (-100.00 %) |
May 31 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 2,117 | 4,234 | 2,117 | 0 to 2.1 K |
May 29 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 3,676 | 2,206 | 19,029 | |
May 29 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 14.10 | 3,676 | 51,832 | 37,500 | 41.2 K to 37.5 K (-8.93 %) |
May 29 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 3,676 | 2,206 | 41,176 | 37.5 K to 41.2 K (+9.80 %) |
May 28 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 82 | 492 | 62,632 | |
May 28 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 4,718 | 28,308 | 62,714 | |
May 28 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 82 | 1,148 | 53,594 | 53.7 K to 53.6 K (-0.15 %) |
May 28 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 82 | 492 | 53,676 | 53.6 K to 53.7 K (+0.15 %) |
May 28 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 4,718 | 66,054 | 53,594 | 58.3 K to 53.6 K (-8.09 %) |
May 28 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 4,718 | 28,308 | 58,312 | 53.6 K to 58.3 K (+8.80 %) |
May 28 2013 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 13.94 | 12,500 | 174,250 | 12,500 | |
May 28 2013 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 13.94 | 12,500 | 174,250 | 12,500 | |
May 28 2013 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Option Exercise | A | 13.94 | 12,500 | 174,250 | 12,500 | |
May 28 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Option Exercise | A | 13.94 | 12,500 | 174,250 | 12,500 | |
May 28 2013 | CCXI | ChemoCentryx, Inc. | KLEIN IRA | Director | Option Exercise | A | 13.94 | 25,000 | 348,500 | 25,000 | |
May 24 2013 | CCXI | ChemoCentryx, Inc. | PENHOET EDWARD | Director | Option Exercise | A | 13.94 | 12,500 | 174,250 | 12,500 | |
May 22 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 200 | 1,200 | 67,432 | |
May 22 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 200 | 2,800 | 53,594 | 53.8 K to 53.6 K (-0.37 %) |
May 22 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 200 | 1,200 | 53,794 | 53.6 K to 53.8 K (+0.37 %) |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 5,000 | 30,000 | 67,632 | |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 10,000 | 60,000 | 72,632 | |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 13.59 | 5,000 | 67,973 | 53,594 | 58.6 K to 53.6 K (-8.53 %) |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 5,000 | 30,000 | 58,594 | 53.6 K to 58.6 K (+9.33 %) |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.16 | 10,000 | 141,598 | 53,594 | 63.6 K to 53.6 K (-15.72 %) |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 10,000 | 60,000 | 63,594 | 53.6 K to 63.6 K (+18.66 %) |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 3,566 | 15,334 | 32,170 | |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 5,852 | 3,511 | 22,705 | |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 14.23 | 6,250 | 88,919 | 37,500 | 43.8 K to 37.5 K (-14.29 %) |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 14.13 | 3,566 | 50,404 | 43,750 | 47.3 K to 43.8 K (-7.54 %) |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 3,566 | 15,334 | 47,316 | 43.8 K to 47.3 K (+8.15 %) |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 13.90 | 5,852 | 81,315 | 43,750 | 49.6 K to 43.8 K (-11.80 %) |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 5,852 | 3,511 | 49,602 | 43.8 K to 49.6 K (+13.38 %) |
May 17 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 799 | 1,598 | 154,712 | |
May 17 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 14.38 | 799 | 11,486 | 0 | 799 to 0 (-100.00 %) |
May 17 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 799 | 1,598 | 799 | 0 to 799 |
May 17 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 14.11 | 5,000 | 70,569 | 55,000 | 60 K to 55 K (-8.33 %) |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.04 | 7,600 | 106,728 | 2,171,087 | 2.2 M to 2.2 M (-0.35 %) |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.04 | 7,600 | 106,728 | 2,171,087 | 2.2 M to 2.2 M (-0.35 %) |
Apr 12 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 1,500 | 900 | 28,557 | |
Apr 12 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 14.10 | 1,500 | 21,150 | 43,750 | 45.3 K to 43.8 K (-3.31 %) |
Apr 12 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 1,500 | 900 | 45,250 | 43.8 K to 45.3 K (+3.43 %) |
Apr 12 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 3,979 | 23,874 | 82,632 | |
Apr 12 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.03 | 3,979 | 55,829 | 53,594 | 57.6 K to 53.6 K (-6.91 %) |
Apr 12 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 3,979 | 23,874 | 57,573 | 53.6 K to 57.6 K (+7.42 %) |
Apr 12 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 3,979 | 23,874 | 82,632 | |
Apr 12 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.03 | 3,979 | 55,829 | 53,594 | 57.6 K to 53.6 K (-6.91 %) |
Apr 12 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 3,979 | 23,874 | 57,573 | 53.6 K to 57.6 K (+7.42 %) |
Apr 12 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.02 | 2,312 | 32,409 | 2,178,687 | 2.2 M to 2.2 M (-0.11 %) |
Apr 12 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 217 | 3,038 | 2,180,999 | 2.2 M to 2.2 M (-0.01 %) |
Apr 05 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 13.49 | 5,000 | 67,468 | 60,000 | 65 K to 60 K (-7.69 %) |
Apr 05 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 13.47 | 6,250 | 84,175 | 43,750 | 50 K to 43.8 K (-12.50 %) |
Apr 02 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 64 | 384 | 86,611 | |
Apr 02 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 957 | 5,742 | 86,675 | |
Apr 02 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 64 | 896 | 53,594 | 53.7 K to 53.6 K (-0.12 %) |
Apr 02 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 64 | 384 | 53,658 | 53.6 K to 53.7 K (+0.12 %) |
Apr 02 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 957 | 13,398 | 53,594 | 54.6 K to 53.6 K (-1.75 %) |
Apr 02 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 957 | 5,742 | 54,551 | 53.6 K to 54.6 K (+1.79 %) |
Apr 02 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 200 | 2,800 | 2,181,216 | 2.2 M to 2.2 M (-0.01 %) |
Apr 02 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 556 | 7,784 | 2,181,416 | 2.2 M to 2.2 M (-0.03 %) |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.75 | 75 | 1,031 | 2,181,972 | 2.2 M to 2.2 M (0.00 %) |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.18 | 4,215 | 59,763 | 2,182,047 | 2.2 M to 2.2 M (-0.19 %) |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.11 | 1,772 | 24,998 | 2,186,262 | 2.2 M to 2.2 M (-0.08 %) |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.07 | 1,790 | 25,192 | 2,188,034 | 2.2 M to 2.2 M (-0.08 %) |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.02 | 1,649 | 23,118 | 2,189,824 | 2.2 M to 2.2 M (-0.08 %) |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.07 | 7,300 | 102,721 | 2,191,473 | 2.2 M to 2.2 M (-0.33 %) |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 1,989 | 3,978 | 155,511 | |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 14.27 | 1,989 | 28,383 | 0 | 2 K to 0 (-100.00 %) |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 1,989 | 3,978 | 1,989 | 0 to 2 K |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 1,783 | 7,667 | 35,736 | |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 3,276 | 1,966 | 30,057 |